Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03782701 · ClinicalTrials.gov registry record · Phase 4
The Effect of Lumify™ Eyedrops on Eyelid Position
A Phase 4 study of Eyelid Droop, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT03782701 is a Phase 4 study of Eyelid Droop that has completed, run by University of Miami. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03782701, a Phase 4 study of Eyelid Droop, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to see if Lumify™ has an effect on eyelid position.
Conditions Studied
Interventions
- DRUG Brimonidine tartrate ophthalmic solution 0.025%
- OTHER Sterile balanced saline solution
Study Locations (1)
Florida
- Bascom Palmer Eye Institute - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2020-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03782701
The ClinicalTrials.gov registry entry for NCT03782701 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eyelid Droop appearing as the primary indexed condition, and to 2 interventions - of which Brimonidine tartrate ophthalmic solution 0.025% is the first listed.
NCT03782701 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03782701 about?
NCT03782701 is a clinical study titled "The Effect of Lumify™ Eyedrops on Eyelid Position". The purpose of the research is to see if Lumify™ has an effect on eyelid position.
What is the current status of trial NCT03782701?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2019-06-18. Estimated completion is 2020-04-01.
What conditions does trial NCT03782701 study?
This clinical trial studies the following conditions: Eyelid Droop.
What interventions are being tested in trial NCT03782701?
The interventions under investigation include: Brimonidine tartrate ophthalmic solution 0.025% (DRUG), Sterile balanced saline solution (OTHER).
Who is sponsoring clinical trial NCT03782701?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03782701 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eyelid Droop
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.